Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- US dollar retreats from 18-month high as oil slips
- UNDP poverty index counts 1.2 billion across 108 countries
- Santa Clarita Bike Fire at 81% after 172-acre burn
- Erie home shooting kills eight victims and gunman
- S&P 500 bull market enters fifth year near record highs
- US and European stocks close higher as bond yields ease fast
- AI Capital expenditure will continue to rise by 10-20% in 2027
- Jaguar Type 01 electric GT debuts with 1,030 PS
Browsing: Health
CALIFORNIA: A California jury has awarded $25 million, to a U.S. man who said he developed a chronic lung disease after years of using a butter flavored version of PAM cooking spray. The verdict was returned Feb. 4 in Los Angeles County Superior
GENEVA: The World Health Organization has granted prequalification to an additional novel oral polio vaccine type 2, expanding the pool of quality assured vaccines that can be bought for international immunization programmes and deployed in outbreak settings. WHO said the decision
WASHINGTON: The U.S. Food and Drug Administration has declined to accept for review Moderna’s application to license its seasonal influenza vaccine candidate mRNA-1010, issuing a refusal-to-file letter that stops the agency’s formal review process at the filing stage. Moderna said the FDA’s Center
MENA Newswire, WASHINGTON: U.S. regulators have classified a recall affecting more than 80,000 single serve coffee pods made for Keurig brewers after a labeling error raised concerns for consumers who avoid caffeine. The action covers McCafé Premium Roast Decaf Coffee K-Cup pods distributed
INDIANAPOLIS, December 12, 2025: Eli Lilly and Co. announced that its next-generation obesity drug, retatrutide, achieved significant weight loss and reduced knee pain in a late-stage Phase 3 trial, underscoring its potential as a major advance in obesity and osteoarthritis treatment.
WASHINGTON, D.C., December 8, 2025: A New Jersey-based pharmaceutical manufacturer has voluntarily recalled more than 11,000 bottles of a high blood pressure medication after tests found potential cross-contamination with another drug, according to the U.S. Food and Drug Administration (FDA).
WASHINGTON, November 28, 2025: The U.S. Food and Drug Administration (FDA) has expanded a nationwide recall of imported cookware after new testing confirmed that several products may release hazardous levels of lead into food, posing long-term health risks to consumers.
WASHINGTON, November 24, 2025: Scientists at the Massachusetts Institute of Technology have identified a method that may restore vision in individuals affected by amblyopia, commonly known as “lazy eye,” by temporarily resetting the retina to an early developmental state. The
WASHINGTON, November 8, 2025: The United States Department of State has issued new instructions to consular offices worldwide expanding the list of medical conditions that may lead to visa denials. Under the updated guidance, chronic illnesses including obesity, diabetes, and cardiovascular disease are
Washington, October 31, 2025: The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of more than 580,000 bottles of the blood pressure drug Prazosin Hydrochloride after testing revealed elevated levels of a nitrosamine impurity known to increase
